Induction of intracellular signalling in human endothelial cells by the hyaluronan-binding protease involves two distinct pathways

Biological Chemistry

Volumn 387, Issue 9, 2006, Pages 1275-1283

  Kreß, Julia Anne ^a,b   Seitz, Rainer ^a   Dodt, Johannes ^a   Etscheid, Michael ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

bFGF; Bradykinin; Calcium; ERK 1 2; HABP; HUVECs

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BRADYKININ; CALCIUM ION; CELL SURFACE RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; HYALURONAN BINDING PROTEASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYC PROTEIN; PROTEIN P42; PROTEIN P44; RAF PROTEIN; SERINE PROTEINASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; BLOOD CLOT LYSIS; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL LINE; CELL MOTILITY; CELL STIMULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYMOLOGY; FUNCTIONAL PROTEOMICS; GENE EXPRESSION; HUMAN; HUMAN CELL; ISOENZYME ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION;

BRADYKININ; CALCIUM; CELLS, CULTURED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ENDOTHELIAL CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, BRADYKININ B2; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION;

EID: 33748743462     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2006.158     Document Type: Article

References (60)

1. Bashkin, P., Klagsbrun, M., Doctrow, S., Shvan, C.M., Folkman, J., and Vlodavsky, I. (1989). Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparanase and heparin-like molecules. Biochemistry 28, 1737-1743.
2. Benezra, M., Vlodavsky, I., Ishai-Michaeli, R., Neufeld, G., and Bar-Shavit, R. (1993). Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix. Blood 81, 3324-3331.
3. Bernier, S.G., Haldar, S., and Michel, T. (2000). Bradykinin-regulated interactions of the mitogen-activated protein kinase pathway with the endothelial nitric-oxide synthase. J. Biol. Chem. 275, 30707-30715.
4. Boyd, K.E. and Farnham, P.J. (1999). Identification of target genes of oncogenic transcription factors. Proc. Soc. Exp. Biol. Med. 222, 9-28.
5. Busse, R. and Fleming, I. (1996). Molecular responses of endothelial tissue to kinins. Diabetes 45, S8-S13.
6. Busse, R. and Lamontagne, D. (1991). Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 344, 126-129.
7. 2+ oscillations in Madin-Darby canine kidney cells only when proteolytically active. J. Biol. Chem. 271, 29034-29042.
8. Choi-Miura, N.H., Tobe, T., Sumiya, J., Nakano, Y., Sano, Y., Mazda, T., and Tomita, M. (1996). Purification and characterization of a novel hyaluronan-binding protein (PHBP) from human plasma: it has three EGF, a kringle and a serine protease domain, similar to hepatocyte growth factor activator. J. Biochem. 119, 1157-1165.
9. Cines, D.B., Pollak, E.S., Buck, C.A., Loscalzo, J., Zimmerman, G.A., McEver, R.P., Pober, J.S., Wick, T.M., Konkle, B.A., Schwartz, B.S., et al. (1998). Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91, 3527-3561.
10. Colman, R.W. and Schmaier, A.H. (1997). Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 90, 3819-3843.
11. Colman, R.W., Pixley, R.A., Najamunnissa, S, Yan, W., Wang, J., Mazar, A., and McCrae, K.R. (1997). Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor. J. Clin. Invest. 100, 1481-1487.
12. Costa, M., Shen, Y., Maurer, F., and Medcalf, R.L. (1998). Transcriptional regulation of the tissue-type plasminogen-activator gene in human endothelial cells: identification of nuclear factors that recognise functional elements in the tissue-type plasminogen-activator gene promoter. Eur. J. Biochem. 258, 123-131.
13. Coughlin, S.R. (2001). Protease-activated receptors in vascular biology. Thromb. Haemost. 86, 298-307.
14. Dery, O., Corvera, C.U., Steinhoff, M., and Bunnett, N.W. (1998). Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am. J. Physiol. 274, C1429-C1452.
15. Etscheid, M., Hunfeld, A., König, H., Seitz, R., and Dodt, J. (2000). Activation of proPHBSP, the zymogen of a plasma hyaluronan binding serine protease, by an intermolecular autocatalytical mechanism. Biol. Chem. 381, 1223-1231.
16. Etscheid, M., Beer, N., Fink, E., Seitz, R., and Dodt, J. (2002). The hyaluronan-binding serine protease from human plasma cleaves HMW and LMW kininogen and releases bradykinin. Biol. Chem. 383, 1633-1643.
17. Etscheid, M., Beer, N., Kreß, J.A., Seitz, R., and Dodt, J. (2004). Inhibition of bFGF/EGF-dependent endothelial cell proliferation by the hyaluronan-binding protease from human plasma. Eur. J. Cell Biol. 82, 597-604.
18. Etscheid, M., Beer, N., and Dodt, J. (2005). The hyaluronan-binding protease upregulates ERK1/2 and PI3K/Akt signalling pathways in fibroblasts and stimulates cell proliferation and migration. Cell. Signal. 17, 1486-1494.
19. Fernando, L.P., Fernando, A.N., Joseph, K., and Kaplan, A.P. (2003). Assessment of the role of heparan sulfate in high molecular weight kininogen binding to human umbilical vein endothelial cells. J. Thromb. Haemost. 1, 2444-2449.
20. Fink, E., Schill, W.-B., Fiedler, F., Krassnigg, F., Geiger, R., and Shimamoto, K. (1985). Tissue kallikrein of human seminal plasma is secreted by the prostate gland. Biol. Chem. Hoppe-Seyler 366, 917-924.
21. Fleming, I., Fisslthaler, B., and Busse, R. (1995). Calcium signalling in endothelial cells involves activation of tyrosine kinases and leads to activation of mitogen-activated protein kinases. Circ. Res. 76, 522-529.
22. Freay, A., Johns, A., Adams, D.J., Ryan, U.S., and van Breemen, C. (1989). Bradykinin and inositol 1,4,5-triphosphate-stimulated calcium release from intracellular stores in cultured bovine endothelial cells. Pflüger's Arch. 414, 377-384.
23. Grewal, S.S., Fass, D.M., Yao, H., Ellig, C.L., Goodman, R.H., and Stork, P.J.S. (2000). Calcium and cAMP signals differentially regulate cAMP-responsive element-binding protein function via a Rap1-extracellular signal-regulated kinase pathway. J. Biol. Chem. 275, 34433-34441.
24. Gryglewski, R.J., Botting, R.M., and Vane, J.R. (1988). Mediators produced by the endothelial cell. Hypertension 12, 530-548.
25. 2+-chelators with greatly improved fluorescent properties. J. Biol. Chem. 260, 3340-3350.
26. Hasan, A.A.K., Zisman, T., and Schmaier, A.H. (1998). Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells. Proc. Natl. Acad. Sci. USA 95, 3615-3620.
27. Herbert, J.M., Bono, F., Hérault, J.P., Avril, C., Dol, F., Mares, A.M., and Schaeffner, P. (1998). Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo. J. Clin. Invest. 101, 993-1000.
28. Hunfeld, A., Etscheid, M., König, H., Seitz, R., and Dodt, J. (1999). Detection of a novel plasma serine protease during purification of vitamin K-dependent coagulation factors. FEBS Lett. 456, 290-294.
29. Ishai-Michaeli, R., Eldor, A., and Vlodavsky, I. (1990). Heparanase activity expressed by platelets, neutrophils and lymphoma cells releases active fibroblast growth factor from extracellular matrix. Cell Regul. 1, 833-842.
30. Jaffe, E.A., Nachman, R.L., Becker, C.G., and Minick, C.R. (1973). Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52, 2745-2756.
31. Joseph, K., Ghebrehiwet, B., Peerschke, E.I., Reid, K.B., and Kaplan, A.P. (1996). Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular 'heads' of C1q (gC1q-R). Proc. Natl. Acad. Sci. USA 93, 8552-8557.
32. Kannemeier, C., Al-Fakhri, N., Preissner, K.T., and Kanse, S.M. (2004). Factor VII-activating protease (FSAP) inhibits growth factor-mediated cell proliferation and migration of vascular smooth muscle cells. FASEB J. 18, 728-730.
33. Ko, F.N., Yang, Y.C., Huang, S.C., and Ou, J.T. (1996). Coagulation factor Xa stimulates platelet-derived growth factor release and mitogenesis in cultured vascular smooth muscle cells of rat. J. Clin. Invest. 98, 1493-1501.
34. Kooistra, T., Schrauwen, Y., Arts, J., and Emeis, J.J. (1994). Regulation of endothelial cell t-PA synthesis and release. Int. J. Hematol. 59, 233-255.
35. Laemmli, U.K. (1970). Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 227, 680-685.
36. Lobb, R.R. (1988). Thrombin inactivates acidic fibroblast growth factor but not basic fibroblast growth factor. Biochemistry 27, 2572-2578.
37. Macfarlane, S.R., Seatter, M.J., Kanke, T., Hunter, G.D., and Plevin, R. (2001). Proteinase-activated receptors. Pharmacol. Rev. 53, 245-282.
38. Marceau, F. (1995). Kinin B1 receptors: a review, Immunopharmacology 30, 1-26.
39. Mayadas, T., Wagner, D.D., and Simpson, P.J. (1989). von Willebrand factor biosynthesis and partitioning between constitutive and regulated pathways of secretion after thrombin stimulation. Blood 73, 706-711.
40. Mignatti, P., Morimoto, T., and Rifkin, D.B. (1992). Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J. Cell Physiol. 151, 81-93.
41. Molloy, C., Pawlowski, J.E., Taylor, D.S., Turner, C.E., Weber, H., and Peluso, M. (1996). Thrombin receptor activation elicits rapid protein tyrosine phosphorylation and stimulation of the Raf-1/MAP kinase pathway preceding delayed mitogenesis in cultured aortic smooth muscle cells. J. Clin. Invest. 97, 1173-1183.
42. 2+ dynamics in endothelial cells. Am. J. Physiol 253, C588-C598.
43. Nakazawa, F., Kannemeier, C., Shibamiya, A., Song, Y., Tzima, E., Schubert, U., Koyama, T., Niepmann, M., Trusheim, H., Engelmann, B., and Preissner, K.T. (2005). Extracellular RNA is a natural cofactor for the (auto-)activation of factor VII-activating protease (FSAP). Biochem. J. 385, 831-838.
44. Nawroth, P., Kisiel, W., and Stern, D. (1985). The role of endothelium in the homeostatic balance of haemostasis. Clin. Haematol. 14, 531-546.
45. Poulsen, L.K., Jacobsen, N., Sorensen, B.B., Bergenhem, N.C.H., Kelly, J.D., Forster, D.C., Thastrup, O., Ezban, M., and Petersen, L.C. (1998). Signal transduction in the mitogen-activated protein kinase pathway induced by binding of factor VIIa to tissue factor. J. Biol. Chem. 273, 6228-6232.
46. Quinn, P.G. (2002). Mechanisms of basal and kinase-inducible transcription activation by CREB. Prog. Nucleic Acid Res. Mol. Biol. 72, 269-305.
47. Renné, T., Dedio, J., David, G., and Müller-Esterl, W. (2000). High molecular weight kininogen utilizes heparan sulfate proteoglycans for accumulation on endothelial cells. J. Biol. Chem. 275, 33688-33696.
48. Renné, T., Schuh, K., and Müller-Esterl, W. (2005). Local bradykinin formation is controlled by glycosaminoglycans. J. Immunol. 175, 3377-3385.
49. Römisch, J., Feußner, A., Vermöhlen, S., and Stöhr, H.-A. (1999). A protease isolated from human plasma activating factor VII independent of tissue factor. Blood Coagul. Fibrinol. 10, 471-479.
50. Römisch, J., Vermöhlen, S., Feußner, A., and Stöhr, H.-A. (2000). The FVII activating protease cleaves single-chain plasminogen activators. Haemostasis 29, 292-299.
51. 2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor. J. Biol. Chem. 270, 4650-4660.
52. Saksela, O., Moscatelli, D., Sommer, A., and Rifkin, D.B. (1988). Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J. Cell Biol. 107, 743-751.
53. Schmaier, A.H., Kuo, A., Lundberg, D., Murray, S., and Cines, D.B. (1988). Expression of high molecular weight kininogen on human umbilical vein endothelial cells. J. Biol. Chem. 263, 16327.
54. Schmaier, A.H. (2000). Plasma kallikrein/kinin system: a revised hypothesis for its activation and its physiologic contributions. Curr. Opin. Hematol. 7, 261-265.
55. Shariat-Madar, Z., Mahdi, F., and Schmaier, A.H. (2001). Factor XI assembly and activation on human umbilical vein endothelial cells in culture. Thromb. Haemost. 85, 544-551.
56. Sommer, A. and Rifkin, D.B. (1989). Interaction of heparin with human basic fibroblast growth factor: protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan. J. Cell Physiol. 138, 215-220.
57. Sorensen, B.B., Freskgard, P.O., Nielsen, L.S., Rao, L.V., Ezban, M., and Petersen, L.C. (1999). Factor VIIa-induced p44/42 mitogen-activated protein kinase activation requires the proteolytic activity of factor VIIa and is independent of the tissue factor cytoplasmic domain. J. Biol. Chem. 274, 21349-21354.
58. Sung, C.P., Arleth, A.J., Shikano, K., Berkowitz, B.A. (1988). Characterization and function of bradykinin receptors in vascular endothelial cells. J. Pharmacol. Exp. Ther. 247, 8-13.
59. Towbin, H., Staehelin, T., and Gordon, T. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350-4354.
60. Whitelock, J.M., Murdoch, A.D., Iozzo, R.V., and Underwood, P.A. (1996). The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanase. J. Biol. Chem. 271, 10079-10086.